18 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Recent Progress in Histone Demethylase Inhibitors.

University of Oxford
Inhibition of Histone Demethylases Offers a Novel and Promising Approach for the Treatment of Cancer and Other Diseases.

Therachem Research Medilab (India)
Inhibition of demethylases by GSK-J1/J4.

EpiTherapeutics Aps
Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present).

Hangzhou Normal University
Small-Molecule Inhibitors of the MLL1 CXXC Domain, an Epigenetic Reader of DNA Methylation.

University of Virginia
Design and evaluation of 1,7-naphthyridones as novel KDM5 inhibitors.

Genentech
Identification of potent, selective KDM5 inhibitors.

Constellation Pharmaceuticals
Structure-based design and discovery of potent and selective KDM5 inhibitors.

Celgene
Design of KDM4 Inhibitors with Antiproliferative Effects in Cancer Models.

Celgene Quanticel Research
From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors.

Genentech
Discovery of pyrazolo[1,5-a]pyrimidine-3-carbonitrile derivatives as a new class of histone lysine demethylase 4D (KDM4D) inhibitors.

Sichuan University
Carbocyclic- and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds

Pfizer
Inhibitors of c-fms kinase

Janssen Pharmaceutica
Substituted heteroaryl compounds and methods of use

Calitor Sciences
Steroidal 5a-reductase inhibitors using 4-androstenedione as substrate.

Metropolitan University-Xochimilco
Synthesis, molecular docking studies of hybrid benzimidazole as a-glucosidase inhibitor.

Universiti Teknologi Mara (Uitm)
Small Molecule Inhibitors of 8-Oxoguanine DNA Glycosylase-1 (OGG1).

Oregon Health & Science University